GoPath Diagnostics launched ProstateNow, a prostate-focused germline test designed to assess prognosis, therapeutic options, and inherited risk in patients and high-risk families.
Published
Signal category
Products & Services
Quote
“ProstateNow is GoPath’s prostate‑focused germline test that helps assess prognosis, therapeutic options, and inherited risk in patients and high‑risk families.”
— GoPath Diagnostics team
Company
GoPath Diagnostics
Improving the lives of those affected — or not yet affected — by cancer or other medical conditions.
- Industry
- Medical and Diagnostic Laboratories
- Location
- Buffalo Grove, US
- Company size
- 66 employees
Passionate about advancing cancer diagnostics, GoPath Diagnostics is a leading full-service laboratory specializing in cancer genetics, molecular, and anatomic pathology. Our cutting-edge technologies, global partnerships, and innovative solutions—GeneticsNow, OncoTarget, and OncoTracking—empower healthcare decisions. Proudly based in Buffalo Grove, IL, our comprehensive services encompass IHC, FISH, PCR testing, flow cytometry, cytogenetics, micro-array, and NGS. Join us in the fight against cancer!
Founded 2012